#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Musculoskeletal changes in hypothyroidism


Authors: Kyselovič Michal 2;  Petričko Michal 1;  Kužma Martin 1;  Jackuliak Peter 1;  Killinger Zdenko 1;  Payer Juraj 1
Authors‘ workplace: V. interná klinika LF UK a UNB, Nemocnica Ružinov, Bratislava 1;  Urgentný príjem UNB, Nemocnica Sv. Cyrila a Metoda, Bratislava 2
Published in: Clinical Osteology 2021; 26(2): 89-93
Category:

Overview

Primary hypothyroidism has a significant impact on disorders of all organ systems, including the muscular system and body composition. The aim of this article is to describe main pathoanatomical and pathophysiological changes in the muscular system of patients with primary hypothyroidism and differences in body composition between hypothyroid and euthyroid population. Thyroid hormone deficiency symptoms are termed as hypothyroid myopathy. The emergence of these symptoms can be often caused by insuficient monitoring or lack of treatment of patients with hypothyroidisim. Myoedema can be a common manifestation, but it is often forgotten in clinical practice. On the other hand, generalized muscular pseudohypertrophy, referred to as Hoffmann‘s syndrome in adults
and Kocher-Debre-Semelaigne syndrome in children is rare. In hypothyroidism, there is also a significant loss of muscle mass and strength, however, with good management we can achieve almost complete remission of sarcopenia. In general, it has been shown that with the increased level of the TSH hormone in hypothyroid patients, the amount of fat in the body also increases. Moreover, the amount of fat-free mass decreases, along with muscle strength. Consequently, patients with hypothyroidism have higher body fat compared to the euthyroid population. Thyroid hormones are also involved in bone development and maturation, affect calcium metabolism and, together with GH and PTH, can contribute to significant changes in bone turnover.

Keywords:

hypothyroid myopathy – myoedema – primary hypothyroidism – sarcopenia – skeletal changes


Sources
  1. Shams N, Niaz F, Osmani M. Hoffman Syndrome; Rare Presentation of Hypothyroidism. J Liaquat Uni Med Health Sci 2013; 12(3): 214– 217.
  2. Anwar S, Gibofsky A. Musculoskeletal Manifestations of Thyroid Disease. Rheum Dis Clin North Am 2010; 36(4): 637–646. Dostupné z DOI: <http://dx.doi.org/10.1016/j.rdc.2010.09.001>.        Wiersinga WM, Feingold KR, Anawalt B. Adult Hypothyroidism. Osteopathic Annals 2014; 6:12–23. Dostupné z WWW: <http://www.ncbi. nlm.nih.gov/books/NBK285561>.
  3. Fariduddin MM, Bansal N. Hypothyroid Myopathy. StatPearls [Internet]. Treasure Island (FL). StatPearls Publishing; 2021. Dostupné z DOI: < https://pubmed.ncbi.nlm.nih.gov/30137798>.
  4. Balachandran K, Vignesh G, Mahesh DM et al. Reassessment of elicitation of myoedema in evaluation of overt hypothyroidism: A pilot study. Indian J Endocrinol Metab 2012; 16(Suppl 2): S356-S357. Dostupné z DOI: <http://dx.doi.org/10.4103/2230–8210.104091>.
  5. Asirvatham AR, Balachandran K, Balasubramanian S et al. Myoedema in secondary hypothyroidism: An often unelicited clinical sign of hypothyroid myopathy. BMJ Case Rep 2019; 12(12): e232063. Dostupné z DOI: <http://dx.doi.org/10.1136/bcr-2019–232063>.
  6. Vignesh G, Balachandran K, Kamalanathan S et al. Myoedema: A clinical pointer to hypothyroid myopathy. Indian J Endocrinol Metab 2013; 1 7(2): 3 52. D ostupné z DOI: <http://dx.doi.org/10.4103/2230–8210.109672>.
  7. Tullu MS, Udgirkar VS, Muranjan N et al. Kocher-Debre-Semelaigne Syndrome: Hypothyroidism with Muscle Pseudohypertrophy. Indian J Pediatr 2003; 70(8): 671–673. Dostupné z DOI: <http://dx.doi.org/10.1007/BF02724260>.
  8. Rajvanshi S,,Philip R, Rai GK et al. Kocher-Debre-Semelaigne syndrome. Thyroid Res Pract,[serial online] 2012; 9: 53–55. Dostupné z WWW: <https://www.thetrp.net/text.asp?2012/9/2/53/96047>.
  9. Sindoni A, Rodolico C, Pappalardo MA et al. Hypothyroid myopathy: A peculiar clinical presentation of thyroid failure. Review of the literature. Rev Endocr Metab Disord 2016; 17(4): 499–519. Dostupné z DOI: <http://dx.doi.org/10.1007/s11154–016–9357–0>.
  10. Vasconcellos LF, Peixoto MC, Oliveira TN et al. Hoffman‘s syndrome: pseudohypertrophic myopathy as initial manifestation of hypothyroidism. Case report. Arq Neuropsiquiatr 2003; 61(3B):851–854. Dostupné z DOI: <http://dx.doi.org/10.1590/s0004– 282x2003000500027>.
  11. Morley JE. Hormones and Sarcopenia. Curr Pharm Des 2017; 23(30): 4484–4492. Dostupné z DOI: <http://dx.doi.org/10.2174/1381612823666161123150032>.
  12. Borba VZ, Costa TL, Moreira CA et al. MECHANISMS OF ENDOCRINE DISEASE: Sarcopenia in endocrine and non-endocrine disorders. Eur J Endocrinol 2019; 180(5): R185-R199. Dostupné z DOI:<http://dx.doi.org/10.1530/EJE-18–0937>.
  13. Szlejf C, Suemoto CK, Janovsky CC et al. Thyroid Function and Sarcopenia: Results from the ELSA-Brasil Study. J Am Geriatr Soc 2020; 6 8(7): 1545–1553. Dostupné z DOI: <http://dx.doi.org/10.1111/ jgs.16416>.
  14. Bloise FF, Oliveira TS, Cordeiro A et al. Thyroid Hormones Play Role in Sarcopenia and Myopathies. Front Physiol 2018; 9:560. Dostupné z DOI: <http://dx.doi.org/10.3389/fphys.2018.00560>.
  15. Moon MK, Lee Yj, Choi SH et al. Subclinical hypothyroidism has little influences on muscle mass or strength in elderly people. J Korean M ed S ci 2 010; 2 5(8): 1176–1181. D ostupné z DOI: < http://
  16. dx.doi.org/10.3346/jkms.2010.25.8.1176>.
  17. Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39(4):412–423. Dostupné z DOI: <http://dx.doi.org/10.1093/ageing/ afq034>.
  18. Ríos-Prego M, Anibarro L, Sánchez-Sobrino P. Relationship between thyroid dysfunction and body weight: a not so evident paradigm. I nt J Gen M ed 2 019; 12: 2 99–304. D ostupné z DOI: < http://dx.doi.org/10.2147/IJGM.S206983>.
  19. Sánchez A, Carretto H, Ulla MR et al. Body composition of patients with primary hypothyroidism evaluated by dual-energy x-ray absorptiometry and its changes after treatment with levo-thyroxine. Endocrinologist 2004; 14(6): 321–327. Dostupné z DOI: <http://dx.doi. org/10.1097/01.ten.0000146570.51516.5b>.
  20. Seppel T, Kosel A, Schlaghecke R. Bioelectrical impedance assessment of body composition in thyroid disease. Eur J Endocrinol 1997; 136(5): 493–4988. Dostupné z DOI: <http://dx.doi.org/10.1530/eje.0.1360493>.
  21. Duncan Bassett JH, O‘Shea PJ, Sriskantharajah S et al.Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism. Mol Endocrinol 2007; 21(5): 1095–1107. Dostupné z DOI: <http://dx.doi.org/10.1210/me.2007–0033>.
  22. Duncan Bassett JH, Williams GR. Role of Thyroid Hormones in Skeletal Development and Bone Maintenance. Endocr Rev 2016; 37(2): 135–187. Dostupné z DOI: <http://dx.doi.org/10.1210/er.2015–1106>.
  23. Abe E, Marians RC, Yu W et al. TSH is a negative regulator of skeletal remodeling. C ell 2 003; 115(2): 151–162. D ostupné z DOI: < http:// dx.doi.org/10.1016/s0092–8674(03)00771–2>.
  24. El Hadidy M, Ghonaim M, Abd El Gawad S et al. Impact of severity, duration, and etiology of hyperthyroidism on bone turnover markers and bone mineral density in men. BMC Endocr Disord 2011; 11:15. Dostupné z DOI: <http://dx.doi.org/10.1186/1472–6823–11–15>.
  25. Begic-Karup S, Wagner B, Raber W et al. Serum calcium in thyroid disease. Wien Klin Wochenschr 2001; 113(1–2): 65–68.
Labels
Clinical biochemistry Paediatric gynaecology Paediatric radiology Paediatric rheumatology Endocrinology Gynaecology and obstetrics Internal medicine Orthopaedics General practitioner for adults Radiodiagnostics Rehabilitation Rheumatology Traumatology Osteology
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#